Evidence map›Paper›PMID 30908502›Full record

ArticlePloS one2019

Cost-effective and multifunctional acquisition system for in vitro electrophysiological investigations with multi-electrode arrays.

Leonardo D Garma, Laura Matino, Giovanni Melle, Fabio Moia, Francesco De Angelis, Francesca Santoro, Michele Dipalo

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Leonardo D GarmaCenter for Advanced Biomaterials for Healthcare, Istituto Italiano di Tecnologia, Naples, Italy.ORCID 0000-0003-1220-8397
Laura MatinoCenter for Advanced Biomaterials for Healthcare, Istituto Italiano di Tecnologia, Naples, Italy.
Giovanni MelleIstituto Italiano di Tecnologia, Genoa, Italy.
Fabio MoiaIstituto Italiano di Tecnologia, Genoa, Italy.
Francesco De AngelisIstituto Italiano di Tecnologia, Genoa, Italy.
Francesca SantoroCenter for Advanced Biomaterials for Healthcare, Istituto Italiano di Tecnologia, Naples, Italy.
Michele DipaloIstituto Italiano di Tecnologia, Genoa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In vitro multi-electrode array (MEA) technology is nowadays involved in a wide range of applications beyond neuroscience, such as cardiac electrophysiology and bio-interface studies. However, the cost of commercially available acquisition systems severely limits its adoption outside specialized laboratories with high budget capabilities. Thus, the availability of low-cost methods to acquire signals from MEAs is important to allow research labs worldwide to exploit this technology for an ever-expanding pool of experiments independently from their economic possibilities. Here, we provide a comprehensive toolset to assemble a multifunctional in vitro MEA acquisition system with a total cost 80% lower than standard commercial solutions. We demonstrate the capabilities of this acquisition system by employing it to i) characterize commercial MEA devices by means of electrical impedance measurements ii) record activity from cultures of HL-1 cells extracellularly, and iii) electroporate HL-1 cells through nanostructured MEAs and record intracellular signals.

Indexed as

Action PotentialsAnimalsCell LineCost-Benefit AnalysisElectrophysiological PhenomenaElectrophysiologic Techniques, CardiacElectroporationEquipment DesignMiceMicroelectrodesMyocytes, CardiacSoftware

Identifiers

PMID30908502
PMCPMC6433224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.